AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
For more than 20 years, AbbVie has been dedicated to improving care for people living with immune disorders. As a leader in innovation, we have a longstanding commitment to cutting-edge research to drive exciting developments in inflammatory bowel diseases (IBD), like ulcerative colitis and Crohn’s disease, to help more people living with inflammatory conditions reach their treatment goals. We work hand-in-hand with the gastroenterology community to push boundaries and help shape the IBD management landscape, striving to do whatever it takes to change the lives of those living with IBD and make a positive long-term impact so that no person is left behind.